DXCM vs. MANH
DXCM (DexCom, Inc.) and MANH (Manhattan Associates, Inc.) are both stocks. DXCM operates in Diagnostics & Research (Healthcare), while MANH operates in Software - Application (Technology). Over the past 10 years, DXCM returned 15.17%/yr vs 8.10%/yr for MANH. At a 0.36 correlation, their price movements are largely independent.
Performance
DXCM vs. MANH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DXCM achieves a 13.56% return, which is significantly higher than MANH's -17.54% return. Over the past 10 years, DXCM has outperformed MANH with an annualized return of 15.17%, while MANH has yielded a comparatively lower 8.10% annualized return.
DXCM
- 1D
- 0.16%
- 1M
- 28.68%
- YTD
- 13.56%
- 6M
- 12.56%
- 1Y
- -9.03%
- 3Y*
- -15.73%
- 5Y*
- -5.51%
- 10Y*
- 15.17%
MANH
- 1D
- 1.87%
- 1M
- 13.83%
- YTD
- -17.54%
- 6M
- -17.73%
- 1Y
- -25.90%
- 3Y*
- -9.25%
- 5Y*
- -0.21%
- 10Y*
- 8.10%
DXCM vs. MANH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 13.56% | -14.66% | -37.33% | 9.58% | -15.64% | 45.23% | 69.02% | 82.59% | 108.75% | -3.87% |
MANH Manhattan Associates, Inc. | -17.54% | -35.87% | 25.51% | 77.36% | -21.92% | 47.83% | 31.89% | 88.22% | -14.47% | -6.58% |
Correlation
The correlation between DXCM and MANH is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since Apr 14, 2005 | 0.36 |
Over the past year, the correlation between DXCM and MANH has dropped to 0.16 - well below their long-term average of 0.36, suggesting their price drivers have been diverging.
Fundamentals
DXCM:
$29.67B
MANH:
$8.58B
DXCM:
$2.31
MANH:
$3.57
DXCM:
32.57
MANH:
40.03
DXCM:
0.77
MANH:
1.90
DXCM:
6.29
MANH:
7.88
DXCM:
10.03
MANH:
41.82
DXCM:
$4.82B
MANH:
$1.10B
DXCM:
$2.96B
MANH:
$456.06M
DXCM:
$1.37B
MANH:
$297.27M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DXCM vs. MANH — Risk / Return Rank
DXCM
MANH
DXCM vs. MANH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and Manhattan Associates, Inc. (MANH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DXCM | MANH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.45 | ||
| Sortino ratioReturn per unit of downside risk | +0.74 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 0.91 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | -0.23 | -0.55 | +0.32 |
| Martin ratioReturn relative to average drawdown | -0.40 | -0.97 | +0.57 |
Loading charts...
Drawdowns
DXCM vs. MANH - Drawdown Comparison
The maximum DXCM drawdown since its inception was -94.61%, which is greater than MANH's maximum drawdown of -87.04%. Use the drawdown chart below to compare losses from any high point for DXCM and MANH.
Loading charts...
Drawdown Indicators
| DXCM | MANH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.61% | -87.04% | -7.57% |
Max Drawdown (1Y)Largest decline over 1 year | -38.75% | -46.97% | +8.22% |
Max Drawdown (3Y)Largest decline over 3 years | -60.95% | -60.98% | +0.03% |
Max Drawdown (5Y)Largest decline over 5 years | -66.32% | -60.98% | -5.34% |
Max Drawdown (10Y)Largest decline over 10 years | -66.32% | -60.98% | -5.34% |
Current DrawdownCurrent decline from peak | -53.71% | -53.86% | +0.15% |
Average DrawdownAverage peak-to-trough decline | -36.02% | -39.49% | +3.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.77% | 26.88% | -4.11% |
Volatility
DXCM vs. MANH - Volatility Comparison
DexCom, Inc. (DXCM) and Manhattan Associates, Inc. (MANH) have volatilities of 13.27% and 12.94%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DXCM | MANH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.27% | 12.94% | +0.33% |
Volatility (6M)Calculated over the trailing 6-month period | 25.48% | 32.78% | -7.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.74% | 38.58% | +2.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.98% | 38.14% | +8.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.43% | 39.45% | +8.98% |
Dividends
DXCM vs. MANH - Dividend Comparison
Neither DXCM nor MANH has paid dividends to shareholders.
Financials
DXCM vs. MANH - Financials Comparison
This section allows you to compare key financial metrics between DexCom, Inc. and Manhattan Associates, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DXCM vs. MANH - Profitability Comparison
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a gross profit of 750.30M and revenue of 1.19B. Therefore, the gross margin over that period was 63.0%.
MANH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Manhattan Associates, Inc. reported a gross profit of 0.00 and revenue of 282.22M. Therefore, the gross margin over that period was 0.0%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported an operating income of 255.30M and revenue of 1.19B, resulting in an operating margin of 21.4%.
MANH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Manhattan Associates, Inc. reported an operating income of 64.94M and revenue of 282.22M, resulting in an operating margin of 23.0%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a net income of 199.50M and revenue of 1.19B, resulting in a net margin of 16.7%.
MANH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Manhattan Associates, Inc. reported a net income of 49.30M and revenue of 282.22M, resulting in a net margin of 17.5%.
Frequently Asked Questions
DXCM and MANH have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DXCM has higher volatility (13.27%) compared to MANH (12.94%). In terms of maximum drawdown, DXCM dropped -94.61% vs MANH's -87.04%.
DXCM currently has the higher Sharpe Ratio (-0.22 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DXCM and MANH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer